Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.691 SEK | -5.21% | -1.00% | -5.34% |
20/02 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
20/02 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 3
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Arfolitixorin
100.0
%
| 13 | 100.0 % | 1 | 100.0 % | -94.37% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
100.0
%
| 13 | 100.0 % | 1 | 100.0 % | -94.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 72 | 09/01 |
Magnus Hurst
DFI | Director of Finance/CFO | 68 | 10/01 |
Roger Tell
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Erik Lind
CHM | Chairman | 83 | - |
Sten Nilsson
BRD | Director/Board Member | 76 | 04/01 |
Alain Herrera
BRD | Director/Board Member | 74 | 01/18/01 |
Chairman | 79 | 28/23/28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 161,515,440 | 101,064,675 ( 62.57 %) | 0 | 62.57 % |
Company contact information
Isofol Medical AB
Biotech Center Arvid Wallgrens Backe 20
413 46, Gothenburg
+46 3 17 97 22 80
http://www.isofol.seSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-5.34% | 10.73M | |
+4.30% | 69.17B | |
+12.55% | 9.06B | |
-12.75% | 4.96B | |
+42.38% | 4.47B | |
+5.23% | 3.9B | |
+21.52% | 2.41B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |
- Stock Market
- Equities
- ISOFOL Stock
- Company Isofol Medical AB